Clinically significant CYP2C19 genotypes in patients with myocardial infarction in the northern region of Russia

Clinically significant CYP2C19 genotypes in patients with myocardial infarction in the northern region of Russia

Aim. To determine the associations of allelic variants of the CYP2C19 gene with coronary atherosclerosis and ischemic events in patients with myocardial infarction (MI) living in the Khanty-Mansi Autonomous Okrug — Yugra.Material and methods. This prospective observational study included 203 patient...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Vorobyov, G. I. Lifshits, E. M. Zelenskaya, K. Yu. Batueva, L. V. Kovalenko, I. A. Urvantseva, M. Yu. Donnikov, A. V. Morozkina, K. Yu. Nikolaev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-11-01
Series:	Российский кардиологический журнал
Subjects:	myocardial infarction cyp2c19 genotypes coronary atherosclerosis ischemic events northern region of russia
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5533
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome
by: K. Yu. Nikolaev, et al.
Published: (2018-11-01)

Efficacy of P2Y<sub>12</sub> receptor inhibitors in myocardial infarction in individuals carrying different <i>CYP2C19</i> genotypes living in the northern region of Russia
by: A. S. Vorobyov, et al.
Published: (2024-11-01)

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01)

REGIONAL ASPECTS OF THE GENE POLYMORPHISM VЕGFR2 WITH CORONARY ATHEROSCLEROSIS IN ACUTE CORONARY SYNDROME
by: K. Yu. Nikolaev, et al.
Published: (2017-11-01)

Lipoprotein transport and metabolism markers in patients with myocardial infarction in the Biobank of Yugra blood sample collection
by: A. S. Vorobyov, et al.
Published: (2025-01-01)

THE PROTOCOL: INFLUENCE OF THE COMBINATION CARRIAGE СУР2С19*2 AND *17 ON EFFICACY OF CLOPIDOGREL
by: Е. М. Zelenskaya, et al.
Published: (2017-11-01)

ASSOCIATION OF THE GENE CYP11B2 WITH THE RISK OF ESSENTIAL HYPERTENSION AND ATHEROTHROMBOTIC COMPLICATIONS
by: E. M. Zelenskaya, et al.
Published: (2016-06-01)

Polymorphisms of CYP1A1, CYP1A2, CYP19, and SULT1A1 genes in women with early miscarriage
by: I. N. Noskova, et al.
Published: (2019-12-01)

POLYMORPHISMS OF THE CYP1A1, CYP1A2, CYP19, AND SULT1A1 GENES ARE NOT ASSOCIATED WITH INFERTILITY IN WOMEN WITH GENITAL ENDOMETRIOSIS
by: LARISA N. Danilova, et al.
Published: (2018-09-01)

The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease
by: Nour Haj Saleh, et al.
Published: (2025-04-01)

CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation
by: A. A. Kurylev, et al.
Published: (2018-05-01)

Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern China
by: Li XP, et al.
Published: (2025-05-01)

CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin
by: Rubin Lubomirov, et al.
Published: (2025-04-01)

Modulating effect of Cu(II) complexes with enamine and tetrazole derivatives on CYP2C and CYP3A and their cytotoxic and antiproliferative properties in HepG2 spheroids
by: L. S. Klyushova, et al.
Published: (2022-12-01)

Association of NOTCH4 and CYP2E1 Genetic Variants With Schizophrenia in the Bangladeshi Population: A Case‐Control Study
by: Md. Shalahuddin Millat, et al.
Published: (2024-12-01)

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
by: T. A. Bairova, et al.
Published: (2014-11-01)

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019-02-01)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024-05-01)

Exploring the Pharmacogenetic Landscape: Identification of Clinically Relevant Genotypes by a Nation-Wide Medical Testing Laboratory in Romania
by: Cristina Pop, et al.
Published: (2025-06-01)

Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017-11-01)

DNA Methylation in the CYP3A Distal Regulatory Region (DRR) Is Associated with the Expression of CYP3A5 and CYP3A7 in Human Liver Samples
by: Joseph M. Collins, et al.
Published: (2024-11-01)

CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER
by: L. N. Lyubchenko, et al.
Published: (2017-12-01)

Predictors of angina pain relapse after coronary stenting for acute coronary syndrome in Buryats
by: E. M. Zelenskaya, et al.
Published: (2023-11-01)

Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment Outcomes
by: Lauren Varney, et al.
Published: (2025-06-01)

Establishment of Acenocoumarol Pharmacogenetic Algorithm Including CYP2C9 and VKORC1 Genotypes in Bulgarian Patients Treated with Coumarin Anticoagulants
by: Tzveova R., et al.
Published: (2025-06-01)

Expression profiles of CYP1A1 and CYP1B1 enzymes in Non-small Cell Lung Cancer of Turkish Patients
by: H. Bayram, et al.
Published: (2025-03-01)

CYP2C19‐Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients
by: Yoshiki Katada, et al.
Published: (2025-08-01)

The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients
by: Salha Jokhab, et al.
Published: (2025-04-01)

Genetic Polymorphism of <i>CYP2R1</i>, <i>CYP27A1</i>, <i>CYP27B1</i>, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study
by: Mohamed Abouzid, et al.
Published: (2025-05-01)

CYP3A4 and CYP3A5 Genes in Cyclophosphamide-treated Chronic Lymphocytic Leukemia Patients: A Pharmacogenetics Study
by: Heba M. Elmaraghy, et al.
Published: (2025-06-01)

CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes andphenytoin adverse reactions correlation
by: Carlos Alexandre Twardowschy, et al.
Published: (2011-04-01)

In vivo effects of bempedoic acid on microdosed CYP probe drugs
by: Felicitas Stoll, et al.
Published: (2025-04-01)

HLA typing results and their significance for population of children with type 1 diabetes mellitus in Khanty-Mansi Autonomous Okrug-Yugra region
by: Naina A. Yusupova, et al.
Published: (2025-02-01)

Afro-Latin American Pharmacogenetics of <i>CYP2D6</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Dominicans: A Study from the RIBEF-CEIBA Consortium
by: Mariela Guevara, et al.
Published: (2024-10-01)

Nanopore sequencing-based genotyping suggested an association between CYP2D6 function and susceptibility to anxiety and depression
by: Eng Wee Chua, et al.
Published: (2025-02-01)

The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy
by: A. A. Muradyan, et al.
Published: (2020-10-01)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Study on Phenotypical Activity of Isoenzyme CYP3A4 in Children
by: B. I. Kantemirova, et al.
Published: (2020-05-01)

DISTRIBUTION OF POLYMORPHIC VARIANTS OF THE CYP1A1 AND CYP1A2 GENES IN THE MONGOLOID AND CAUCASOID POPULATION OF THE SOUTH OF KUZBASS
by: Фаина Анисимовна Лузина, et al.
Published: (2021-08-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)